Trial Outcomes & Findings for A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters (NCT NCT01065350)
NCT ID: NCT01065350
Last Updated: 2013-05-03
Results Overview
Blood pressure was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The percentage of subjects experiencing decreases in SBP of greater than 20% during the specified time intervals is reported, as compared to the baseline systolic blood pressure reading. There are two numbers in a blood pressure reading, and they are expressed in millimeters of mercury (mm Hg). This tells how high in millimeters the pressure of your blood raises a column of mercury. The numbers usually are expressed in the form of a fraction; an example of a blood pressure reading is 120/80 mm Hg. The first, or top, number (120 in the example) is the systolic pressure. The systolic pressure is the measure of your blood pressure as the heart contracts and pumps blood.
COMPLETED
NA
85 participants
Baseline, 5 minutes, 10 minutes, 30 minutes post induction
2013-05-03
Participant Flow
Patients requiring surgical procedures with general anesthesia were recruited and enrolled at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire from December 2010 to March 2011.
Participant milestones
| Measure |
Propofol
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Overall Study
STARTED
|
43
|
42
|
|
Overall Study
COMPLETED
|
43
|
41
|
|
Overall Study
NOT COMPLETED
|
0
|
1
|
Reasons for withdrawal
| Measure |
Propofol
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Overall Study
Received incorrect drug allocation
|
0
|
1
|
Baseline Characteristics
A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters
Baseline characteristics by cohort
| Measure |
Propofol
n=43 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=41 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose. One subject in the ketofol group was excluded from analysis due to incorrect study drug assignment and outside the protocol-specified dose.
|
Total
n=84 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age Continuous
|
43 years
STANDARD_DEVIATION 11 • n=5 Participants
|
42 years
STANDARD_DEVIATION 12 • n=7 Participants
|
42.68 years
STANDARD_DEVIATION 11.51 • n=5 Participants
|
|
Sex: Female, Male
Female
|
28 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
55 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
15 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
43 participants
n=5 Participants
|
41 participants
n=7 Participants
|
84 participants
n=5 Participants
|
|
Body Weight
|
69.2 kilograms
STANDARD_DEVIATION 11.7 • n=5 Participants
|
68.9 kilograms
STANDARD_DEVIATION 11.2 • n=7 Participants
|
68.97 kilograms
STANDARD_DEVIATION 11.41 • n=5 Participants
|
|
Body Height
|
169.9 centimeters
STANDARD_DEVIATION 9.1 • n=5 Participants
|
168.9 centimeters
STANDARD_DEVIATION 9.2 • n=7 Participants
|
169.40 centimeters
STANDARD_DEVIATION 9.03 • n=5 Participants
|
|
Systolic Blood Pressure
|
125 millimeters of mercury (mm Hg)
STANDARD_DEVIATION 17 • n=5 Participants
|
122 millimeters of mercury (mm Hg)
STANDARD_DEVIATION 15 • n=7 Participants
|
124.19 millimeters of mercury (mm Hg)
STANDARD_DEVIATION 16.41 • n=5 Participants
|
|
Diastolic Blood Pressure
|
76 millimeters of mercury (mm Hg)
STANDARD_DEVIATION 12 • n=5 Participants
|
76 millimeters of mercury (mm Hg)
STANDARD_DEVIATION 10 • n=7 Participants
|
76 millimeters of mercury (mm Hg)
STANDARD_DEVIATION 11 • n=5 Participants
|
|
Heart Rate
|
72 beats per minute
STANDARD_DEVIATION 16 • n=5 Participants
|
73 beats per minute
STANDARD_DEVIATION 14 • n=7 Participants
|
73 beats per minute
STANDARD_DEVIATION 15 • n=5 Participants
|
|
American Society of Anesthesiology (ASA) Physical Status
ASA Status 1
|
21 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
35 Participants
n=5 Participants
|
|
American Society of Anesthesiology (ASA) Physical Status
ASA Status 2
|
22 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
49 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes, 30 minutes post inductionPopulation: 85 patients were enrolled (43 Propofol/42 Ketofol). However, one subject randomized to the ketofol group received the wrong study drug and in a larger dose than indicated in protocol. This subject was excluded from the analysis and baseline measures.
Blood pressure was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The percentage of subjects experiencing decreases in SBP of greater than 20% during the specified time intervals is reported, as compared to the baseline systolic blood pressure reading. There are two numbers in a blood pressure reading, and they are expressed in millimeters of mercury (mm Hg). This tells how high in millimeters the pressure of your blood raises a column of mercury. The numbers usually are expressed in the form of a fraction; an example of a blood pressure reading is 120/80 mm Hg. The first, or top, number (120 in the example) is the systolic pressure. The systolic pressure is the measure of your blood pressure as the heart contracts and pumps blood.
Outcome measures
| Measure |
Propofol
n=43 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=41 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Percent of Subjects With a Greater Than 20% Decrease in Systolic Blood Pressure (SBP) Following Induction of General Anesthesia
SBP baseline to 5 minutes
|
48 Percentage of subjects
Interval 2.07 to 26.15
|
12 Percentage of subjects
|
|
Percent of Subjects With a Greater Than 20% Decrease in Systolic Blood Pressure (SBP) Following Induction of General Anesthesia
SBP baseline to 10 minutes
|
67 Percentage of subjects
|
39 Percentage of subjects
|
|
Percent of Subjects With a Greater Than 20% Decrease in Systolic Blood Pressure (SBP) Following Induction of General Anesthesia
SBP baseline to 30 minutes
|
76 Percentage of subjects
|
68 Percentage of subjects
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes, 30 minutes post inductionPopulation: 85 patients were enrolled (43 Propofol/42 Ketofol). However, one subject randomized to the ketofol group received the wrong study drug and in a larger dose than indicated in protocol. This subject was excluded from the analysis and baseline measures.
Blood pressure was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The percentage of subjects experiencing decreases in DBP of greater than 20% during the specified time intervals is reported, as compared to the baseline DBP reading. The second or lower number of a blood pressure reading is the DBP and is the measure taken when your heart is at rest.
Outcome measures
| Measure |
Propofol
n=43 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=41 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Percent of Subjects With a Greater Than 20% Decrease in Diastolic Blood Pressure (DBP) Following Induction of General Anesthesia
DBP baseline to 5 minutes
|
48 Percentage of subjects
|
17 Percentage of subjects
|
|
Percent of Subjects With a Greater Than 20% Decrease in Diastolic Blood Pressure (DBP) Following Induction of General Anesthesia
DBP baseline to 10 minutes
|
62 Percentage of subjects
|
41 Percentage of subjects
|
|
Percent of Subjects With a Greater Than 20% Decrease in Diastolic Blood Pressure (DBP) Following Induction of General Anesthesia
DBP baseline to 30 minutes
|
90 Percentage of subjects
|
78 Percentage of subjects
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes, 30 minutes post inductionPopulation: 85 patients were enrolled (43 Propofol/42 Ketofol). However, one subject randomized to the ketofol group received the wrong study drug and in a larger dose than indicated in protocol. This subject was excluded from the analysis and baseline measures.
MAP was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The percentage of subjects experiencing decreases in MAP of greater than 20% during the specified time intervals is reported, as compared to the baseline MAP reading.
Outcome measures
| Measure |
Propofol
n=43 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=41 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Percent of Subjects With a Greater Than 20% Decrease in Mean Arterial Pressure (MAP) Following Induction of General Anesthesia
MAP baseline to 5 minutes
|
44 Percentage of subjects
|
10 Percentage of subjects
|
|
Percent of Subjects With a Greater Than 20% Decrease in Mean Arterial Pressure (MAP) Following Induction of General Anesthesia
MAP baseline to 10 minutes
|
60 Percentage of subjects
|
35 Percentage of subjects
|
|
Percent of Subjects With a Greater Than 20% Decrease in Mean Arterial Pressure (MAP) Following Induction of General Anesthesia
MAP baseline to 30 minutes
|
83 Percentage of subjects
|
75 Percentage of subjects
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionPopulation: The analysis population of 41/40 (vs. 43/41 at baseline) is due to the NICOM not functioning properly during certain aspects of the procedure and therefore, did not provide a number.
CO was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in CO as compared to baseline CO during the specified time intervals is reported. CO is defined as the quantity of blood ejected per minute by the heart into the systemic circulation. It is the product of the heart rate (HR) (beats per minute) times the stroke volume (SV) (milliliters of blood ejected during each contraction).
Outcome measures
| Measure |
Propofol
n=41 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=40 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Cardiac Output (CO)
5 minutes post induction
|
-0.8 Liters per minute
Standard Deviation 0.8
|
-0.6 Liters per minute
Standard Deviation 0.6
|
|
Average Change in Cardiac Output (CO)
10 minutes post induction
|
-1.0 Liters per minute
Standard Deviation 1.0
|
-0.9 Liters per minute
Standard Deviation 0.8
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionPopulation: The analysis population of 41/40 (vs. 43/41 at baseline) is due to the NICOM not functioning properly during certain aspects of the procedure and therefore, did not provide a number.
CI was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in CI as compared to the baseline CI during the specified time intervals is reported. To determine CI, cardiac output is divided by the body surface area in order to account for body size.
Outcome measures
| Measure |
Propofol
n=41 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=40 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Cardiac Index (CI)
5 minutes post induction
|
-0.4 Liters per minute per m^2 of body area
Standard Deviation 0.4
|
-0.3 Liters per minute per m^2 of body area
Standard Deviation 0.4
|
|
Average Change in Cardiac Index (CI)
10 minutes post induction
|
-0.6 Liters per minute per m^2 of body area
Standard Deviation 0.6
|
-0.5 Liters per minute per m^2 of body area
Standard Deviation 0.5
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionHR was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in HR (as compared to baseline HR) during the specified time intervals is reported.
Outcome measures
| Measure |
Propofol
n=43 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=41 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Heart Rate (HR)
5 minutes post induction
|
-4.0 Beats per minute
Standard Deviation 4.5
|
-4.6 Beats per minute
Standard Deviation 6.0
|
|
Average Change in Heart Rate (HR)
10 minutes post induction
|
-5.2 Beats per minute
Standard Deviation 5.2
|
-7.0 Beats per minute
Standard Deviation 8.0
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionBlood pressure was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in SBP (as compared to baseline SBP) during the specified time intervals is reported.
Outcome measures
| Measure |
Propofol
n=43 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=41 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Systolic Blood Pressure (SBP)
5 minutes post induction
|
-26.3 mmHg
Standard Deviation 16.2
|
-12.5 mmHg
Standard Deviation 12.4
|
|
Average Change in Systolic Blood Pressure (SBP)
10 minutes post induction
|
-30.6 mmHg
Standard Deviation 16.6
|
-21.8 mmHg
Standard Deviation 16.8
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionBlood pressure was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in DBP (as compared to baseline DBP) during the specified time intervals is reported.
Outcome measures
| Measure |
Propofol
n=43 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=41 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Diastolic Blood Pressure (DBP)
5 minutes post induction
|
-15.9 mmHg
Standard Deviation 11.3
|
-8.8 mmHg
Standard Deviation 9.1
|
|
Average Change in Diastolic Blood Pressure (DBP)
10 minutes post induction
|
-19.3 mmHg
Standard Deviation 11.5
|
-14.5 mmHg
Standard Deviation 9.8
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionPopulation: The analysis population of 43/40 (vs. 43/41 at baseline) is due to the NICOM not functioning properly during certain aspects of the procedure and therefore, did not provide a number.
MAP was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in MAP from baseline during the specified time intervals is reported. MAP is a term used in medicine to describe an average blood pressure in an individual. It is defined as the average arterial pressure during a single cardiac cycle.
Outcome measures
| Measure |
Propofol
n=43 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=40 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Mean Arterial Pressure (MAP)
5 minutes post induction
|
-18.7 Millimeters of mercury (mmHg)
Standard Deviation 11.5
|
-9.3 Millimeters of mercury (mmHg)
Standard Deviation 9.4
|
|
Average Change in Mean Arterial Pressure (MAP)
10 minutes post induction
|
-22.6 Millimeters of mercury (mmHg)
Standard Deviation 11.7
|
-16.2 Millimeters of mercury (mmHg)
Standard Deviation 11.1
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionPopulation: The analysis population of 39/38 (vs. 43/41 at baseline) is due to the NICOM not functioning properly during certain aspects of the procedure and therefore, did not provide a number.
TPR was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in TPR from baseline during the specified time intervals is reported. TPR is the overall resistance to blood flow through the systemic blood vessels.
Outcome measures
| Measure |
Propofol
n=39 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=38 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Total Peripheral Resistance (TPR)
5 minutes post induction
|
-261.2 dynes * sec/cm^-5
Standard Deviation 211.9
|
-147.6 dynes * sec/cm^-5
Standard Deviation 161.8
|
|
Average Change in Total Peripheral Resistance (TPR)
10 minutes post induction
|
-321.7 dynes * sec/cm^-5
Standard Deviation 251.3
|
-235.0 dynes * sec/cm^-5
Standard Deviation 226.5
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionPopulation: The analysis population of 39/39 (vs. 43/41 at baseline) is due to the NICOM not functioning properly during certain aspects of the procedure and therefore, did not provide a number.
TPRI was recorded every minute for a total of 30 minutes after anesthesia was induced and results were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in TPRI from baseline during the specified time intervals is reported.
Outcome measures
| Measure |
Propofol
n=39 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=39 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Total Peripheral Resistance Index (TPRI)
5 minutes post induction
|
-457.6 dynes * sec/cm^-5/m^2
Standard Deviation 362.4
|
-275.0 dynes * sec/cm^-5/m^2
Standard Deviation 293.2
|
|
Average Change in Total Peripheral Resistance Index (TPRI)
10 minutes post induction
|
-559.3 dynes * sec/cm^-5/m^2
Standard Deviation 421.0
|
-430.6 dynes * sec/cm^-5/m^2
Standard Deviation 407.5
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionPopulation: The analysis population of 41/40 (vs. 43/41 at baseline) is due to the NICOM not functioning properly during certain aspects of the procedure and therefore, did not provide a number.
SV was recorded every minute for a total of 30 minutes after anesthesia was induced and results were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in SV from baseline during the specified time intervals is reported. SV is the milliliters of blood ejected during each contraction of the heart.
Outcome measures
| Measure |
Propofol
n=41 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=40 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Stroke Volume (SV)
5 minutes post induction
|
-12.2 Milliliters of blood per beat
Standard Deviation 10
|
-7.8 Milliliters of blood per beat
Standard Deviation 7.8
|
|
Average Change in Stroke Volume (SV)
10 minutes post induction
|
-16.4 Milliliters of blood per beat
Standard Deviation 12.8
|
-11.6 Milliliters of blood per beat
Standard Deviation 8.7
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionPopulation: The analysis population of 41/40 (vs. 43/41 at baseline) is due to the NICOM not functioning properly during certain aspects of the procedure and therefore, did not provide a number.
SVI was recorded every minute for a total of 30 minutes after anesthesia was induced and results were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. The average change in SVI (as compared to baseline SVI) during the specified time intervals is reported. To determine SVI, stroke volume is divided by the body surface area in order to account for body size.
Outcome measures
| Measure |
Propofol
n=41 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=40 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Stroke Volume Index (SVI)
10 minutes post induction
|
-9.2 Milliters per beat per m^2 of body area
Standard Deviation 6.8
|
-6.6 Milliters per beat per m^2 of body area
Standard Deviation 4.9
|
|
Average Change in Stroke Volume Index (SVI)
5 minutes post induction
|
-6.8 Milliters per beat per m^2 of body area
Standard Deviation 5.6
|
-4.3 Milliters per beat per m^2 of body area
Standard Deviation 4.3
|
SECONDARY outcome
Timeframe: Baseline, 5 minutes, 10 minutes post inductionPopulation: The analysis population of 38/35 (vs. 43/41 at baseline) is due to the NICOM not functioning properly during certain aspects of the procedure and therefore, did not provide a number.
SVV was recorded every minute for a total of 30 minutes after anesthesia was induced and results were captured via a Non-Invasive Cardiac Output Monitor \[NICOM\], Cheetah Medical, Israel. SVV is a dynamic flow-based parameter and together with cardiac output provides an indication of fluid responsiveness. The average change in SVV (as compared to baseline SVV) during the specified time intervals is reported. SVV is calculated by taking the SVmax - SVmin /\*100/ SV mean.
Outcome measures
| Measure |
Propofol
n=38 Participants
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight. The clinician will receive a 20 milliliter (mL) syringe of propofol. If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
Ketofol
n=35 Participants
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe. The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
|---|---|---|
|
Average Change in Stroke Volume Variation (SVV)
5 minutes post induction
|
-2.2 Percentage of mean stroke volume
Standard Deviation 2.0
|
-2.6 Percentage of mean stroke volume
Standard Deviation 2.2
|
|
Average Change in Stroke Volume Variation (SVV)
10 minutes post induction
|
-2.6 Percentage of mean stroke volume
Standard Deviation 2.1
|
-3.1 Percentage of mean stroke volume
Standard Deviation 2.4
|
Adverse Events
Propofol
Ketofol
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place